MOUNTAIN VIEW, Calif., July 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the initial availability of Qsymia ® (phentermine and topiramate extended-release) capsules CIV in thousands of certified retail pharmacies, ahead of the previously-stated mid-July 2013 schedule. Qsymia, a prescription-only medication, is initially available as of today in approximately 8,000 Walgreens, Costco and Duane Reade retail pharmacies nationwide. VIVUS will continue to certify and add to the Qsymia retail pharmacy network, including well-known national and regional chains as well as independent pharmacies, in the coming weeks and months.
VIVUS Announces Initial Availability Of Qsymia(R) Through Certified Retail Pharmacies
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts